Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Part 1 Article 2: Difference between revisions
From GxPlex
Migrate to Template:ReferenceData for PageForms (GxPlexBot) |
Gxplex admin (talk | contribs) m 1 revision imported |
(No difference)
| |
Latest revision as of 13:50, 16 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 4 — Unit 4.2.4 |
| Scope | HM |
| Document part | Part 1
Article 2 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Electronic signature, Definition |
Content
“electronic signature” means data in electronic form which are attached to or logically associated with other electronic data and which serve as a method of authentication;
